# Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/novel-histone-deacetylase-inhibitors-in-clinical-trials-as-anti-cancer-agents/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jiahuai Tan,Shundong Cang,Yuehua Ma,Richard Petrillo,Delong Liu |
| Citations | 429 |
| DOI | 10.1186/1756-8722-3-5 |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jhoonline.biomedcentral.com/counter/pdf/10.1186/1756-8722-3-5 |
| OpenAlex ID | https://openalex.org/W2158178080 |
| PMID | 20132536 |
| Type | article |
| Year | 2010 |

## Paper authors

- [Shundong Cang](https://scholariq.org/researchers/shundong-cang/)

## Paper primary topic

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)

## Paper topics

- [Histone Deacetylase Inhibitors Research](https://scholariq.org/topics/histone-deacetylase-inhibitors-research/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.